Call Today: 800-889-3898
Submit your Raptiva claim details for a free, no obligation case review
Get Started:
Produced by Genentech and Merck Serono, Raptiva is an injectable medication prescribed in the treatment of psoriasis, an incurable skin condition marked by scaly, red patches. Proper use of Raptiva requires a subcutaneous injection at around the same time each week. Raptiva is classified as an immunosuppressant medication.
However, despite its effectiveness at curbing psoriasis' unsightly symptoms, Raptiva is known to cause some rare but serious side effects, including:
Without treatment, these Raptiva brain infections can be fatal.
Anyone who develops a Raptiva viral infection will have a legal claim and be entitled to compensation for their injuries.
Some Raptiva patients will have a higher risk than others of developing life-threatening infections from this psoriasis drug. Risk factors for Raptiva side effects include having a history of:
To minimize the risk of developing Raptiva infections, it's vital that patients discuss their complete medical history with their doctor before starting a course of Raptiva.
Unfortunately, there is no known cure for viral meningitis PML. Consequently, treatments involve boosting the immune system so the symptoms of the virus eventually dissipate.
For meningitis, this requires bed rest, drinking plenty of fluids and taking over-the-counter fever reducers for about a week. In addition to these treatments, PML may also require use of anti-viral medications.
Patients should:
During a free initial consultation, injured Raptiva patients or families of deceased Raptiva patients can find out if they have a legal claim against Genentech and Merck Serono.
Although it may take months to win a Raptiva settlement, ultimately, plaintiffs who follow through with their case can win compensation for their:
Have You Benn Harmed by a Raptiva Viral Infection? If so, contact us to talk to an experienced Raptiva lawyer who can evaluate your injury and fight to protect your legal rights.
The U.S. Food and Drug Administration (FDA) announced a voluntary Raptiva recall, April 8, 2009. The Psoriasis drug’s manufacturer, Genentech, announced the voluntary Raptiva recall and has begun phasing the drug off the U.S. market. R...
Copyright © 2001 - 2009 Online Lawyer Source | Legal Marketing Site Designed by eJustice